Maccura Biotechnology Co.Ltd (SHE:300463)

SHE:300463 Revenue

Maccura Biotechnology Co.Ltd had revenue of 578.54M CNY in the quarter ending September 30, 2026, with 8.57% growth. This brings the company's total for the last twelve months to 2.18B, down -1.53% year-over-year. In the year 2025, Maccura Biotechnology Co.Ltd had annual revenue of 2.17B, down -14.84%. That makes Maccura Biotechnology Co.Ltd the 13,933rd largest company in the world by revenue and 2,475th in China.

• Revenue (ttm): 2.18B
• Revenue Growth: -1.53%
• P/S Ratio: 2.50
• Revenue / Employee: 756.57K
• Employees: 2,875
• Market Cap: 5.44B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Self Owned Products 1.75B 80.4%
• Agent Products 406.04M 18.7%
• Unallocated Other Business 19.24M 0.9%

By Geography

Chart

• Southwest Region 780.14M 35.9%
• East China 435.26M 20.1%
• Overseas 223.34M 10.3%
• Northern Region 197.11M 9.1%
• South China 193.89M 8.9%
• Central China 134.79M 6.2%
• Northwest District 128.58M 5.9%
• Northeast Region 77.35M 3.6%

Fiscal year ended Dec 31, 2025 See the full SHE:300463 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.17B	-378.29M	-14.84%
Dec 31, 2024	2.55B	-347.01M	-11.98%
Dec 31, 2023	2.90B	-712.64M	-19.75%
Jan 1, 2023	3.61B	-372.24M	-9.35%
Jan 1, 2022	3.98B	276.77M	7.47%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error